Drawing for CASEOFER

USPTO serial 79020657

CASEOFER

Reviewed by CopyMark Law Group

Reg. 3206438Status 404
Filing date
Status date
Registration date
Feb 6, 2007
Examiner
HALMEN, KATHERINE E
Law office
PUBLICATION AND ISSUE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with CASEOFER?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Goods and services

ClassDescriptionStatusFirst use
005Pharmaceutical preparations for the treatment of iron deficiency and iron deficiency anaemiaSECTION 71 - CANCELLED

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Apr 28, 2016DENCNOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG E-MAILED
Apr 28, 2016DETHDEATH OF INTERNATIONAL REGISTRATION
Jun 5, 2015INNTTOTAL INVALIDATION PROCESSED BY THE IB
Dec 20, 2014XXSSGENERIC MADRID TRANSACTION SENT TO IB
Dec 20, 2014XXCRGENERIC MADRID TRANSACTION CREATED
Jun 4, 2014INTRTOTAL INVALIDATION OF REG EXT PROTECTION CREATED
May 15, 2014NREPNEW REPRESENTATIVE AT IB RECEIVED
May 8, 2014NREPNEW REPRESENTATIVE AT IB RECEIVED
Oct 4, 2013C71TCANCELLED SECTION 71
May 23, 2008FINOFINAL DECISION TRANSACTION PROCESSED BY IB
Aug 29, 2007FICSFINAL DISPOSITION NOTICE SENT TO IB
Aug 29, 2007FIMPFINAL DISPOSITION PROCESSED
Aug 23, 2007FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Feb 6, 2007R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Nov 21, 2006PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Nov 1, 2006NPUBNOTICE OF PUBLICATION
Sep 29, 2006PREVLAW OFFICE PUBLICATION REVIEW COMPLETED
Sep 28, 2006ALIEASSIGNED TO LIE
Sep 19, 2006CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER
Sep 16, 2006TEMETEAS/EMAIL CORRESPONDENCE ENTERED
Sep 6, 2006CRFACORRESPONDENCE RECEIVED IN LAW OFFICE
Sep 6, 2006TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Sep 6, 2006TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Sep 6, 2006TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED
Aug 17, 2006RFNTREFUSAL PROCESSED BY IB
Aug 3, 2006RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Aug 3, 2006RFRRREFUSAL PROCESSED BY MPU
Aug 3, 2006RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Aug 2, 2006CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jul 27, 2006DOCKASSIGNED TO EXAMINER
Mar 10, 2006NWAPNEW APPLICATION ENTERED
Mar 9, 2006SDRCSN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB

Frequently asked questions

Related guidance